A Study Evaluating the Gastrointestinal (GI) Safety and Tolerability of Aliskiren Compared to Ramipril in Essential Hypertension

Mise à jour : Il y a 4 ans
Référence : NCT00631917

Femme et Homme

Extrait

This study will evaluate the long-term gastrointestinal (GI) safety and efficacy of aliskiren (300 mg) compared to ramipril (10mg) in patients ≥ 50 years with essential hypertension.


Critère d'inclusion

  • Hypertension


Liens